First-of-its-kind initiative brings clinical-grade eye health diagnostics to China's optical retail sector, with integrated referral pathways to top-tier hospitals GUANGZHOU, China — June 2026 — WISER ASIA, a China-based venture development and market-entry firm focused on European medtech, today announced that its portfolio company WISER Optomed Medical has launched an AI-powered fundus screening program in partnership with Oriental Vision, one of China's most established op